Abstract
Background and objectives: Acute Respiratory Failure (ARF) in Idiopathic Pulmonary Fibrosis (IPF) patients (pts) is associated with poor prognosis, therefore a noninvasive approach, such as noninvasive ventilation (NIV) may represent a good option to turn to. NIV modes: Continuous positive airway pressure (CPAP) in spontaneous breathing (SB) (range 8–10 cmH2O level) is applied in the absence of respiratory acidosis in order to treat hypoxemia with tachypnea. FiO2 is set at the lowest value to keep PaO2 at more than 60 mmHg. Hypercapnia, hypoventilation and respiratory fatigue are treated in assisted/controlled ventilation by face-mask (FM) in Pressure Support ventilation (PSV). Pressure Support (PS) and Positive End Expiratory Pressure (PEEP) level are generally imposed respectively equal to 12–18 and 4–9 cmH2O, titrated to provide a moderate tidal volume (TV) (6–8 mL/kg of predicted body weight). When NIV-Helmet is applied, PS and PEEP baseline levels are respectively set at 10 and 5 cmH2O, both raising in increments of 2–3 cmH2O. FM advantages: higher efficacy in improving CO2 elimination and reducing work of breathing while applying PSV in pts with high respiratory muscle load. Disadvantages: not tolerated in pts who need prolonged MV. Helmet advantages over FM: improved tolerability and lesser air leaks as with a new helmet that can be performed for prolonged periods of time. Disadvantages: because of its larger inner volume, standard helmet is characterized by less efficient rates of pressurization and triggering function, worsening patient–ventilator synchrony. In pts with high respiratory drive and intense inspiratory effort, the risk of patient self-inflicted lung injury (P-SILI) is highly considerable. Conclusions: NIV by helmet in CPAP mode and face-mask in PSV provides relief from dyspnoea and avoids endo-tracheal intubation (ETI).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Hypoxaemic respiratory failure is usually defined as significant hypoxaemia (P/F ≤ 200), tachypnoea (respiratory rate > 30–35 breaths·min−1) or use of accessory respiratory muscles or paradoxical abdominal motion, and a non-COPD diagnosis (e.g. pneumonia and/or acute respiratory distress syndrome (ARDS) [19].
Abbreviations
- % pred:
-
Percent of predicted value
- AE-IPF:
-
Acute exacerbation of IPF
- ARDS:
-
Acute respiratory distress syndrome
- ARF:
-
Acute respiratory failure
- CPAP:
-
Continuous positive airway pressure
- DAD:
-
Diffuse alveolar damage
- DNR:
-
Do not resuscitate
- DP:
-
Driving pressure
- ECCO2R:
-
Extracorporeal CO2 removal
- ETI:
-
Endotracheal intubation
- FEV1:
-
Forced expiratory volume in the 1st second
- FEV1/FVC ratio:
-
Forced expiratory volume in the 1st second/Forced Vital capacity
- FiO2:
-
Inspired oxygen fraction
- FMV:
-
Face-mask ventilation
- FVC:
-
Forced Vital capacity
- GCS:
-
Glasgow Coma Scale score
- HFOT:
-
High flow oxygen therapy
- HRCT:
-
High resolution computed tomography
- ICU:
-
Intensive care unit
- ILD:
-
Interstitial lung disease
- IMV:
-
Invasive mechanical ventilation
- IPF:
-
Idiopathic pulmonary fibrosis
- MOF:
-
Multiple organ failure
- MV:
-
Mechanical ventilation
- NIV:
-
Noninvasive mechanical ventilation
- NMBAs:
-
Neuromuscular blocking
- P/F:
-
PaO2/FiO2: ratio of PaO2 to fraction of inspired oxygen
- PaCO2:
-
Carbon dioxide arterial pressure
- PaO2:
-
Oxygen arterial pressure
- PBW:
-
Predicted body weight
- PEEP:
-
Positive end expiratory pressure
- P-SILI:
-
Patient self-inflicted lung injury percentage (%)
- PSV:
-
Pressure support ventilation
- pts:
-
Patient/s
- RICU:
-
Respiratory intensive care unit
- RR:
-
Respiratory rate
- SaO2:
-
Arterial oxygen saturation
- SAPS:
-
Simplified acute physiology score
- SB:
-
Spontaneous breathing
- TLC:
-
Total lung capacity
- TV:
-
Tidal volume
- UIP:
-
Usual interstitial pneumonia
- VAP:
-
Ventilator-associated pneumonia
- VILI:
-
Ventilator-induced lung injury
- WOB:
-
Work of breathing
References
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824. https://doi.org/10.1164/rccm.2009-040GL.
Olson AL, Gifford AH, Inase N, Fernández Pérez ER, Suda T. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype. Eur Respir Rev. 2018;27(150):180077. https://doi.org/10.1183/16000617.0077-2011.
Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, et al. Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636–43. https://doi.org/10.1164/rccm.200703-463PP.
Raghu G, Rochwerg B, Zhang Y, Garcia CAC, Azuma A, Behr J, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–19. https://doi.org/10.1164/rccm.201506-1063ST.
Mallick S. Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med. 2008;102:1355–9. https://doi.org/10.1016/j.rmed.2008.06.003.
Aliberti S, Messinesi G, Gamberini S, Maggiolin SI, Visca D, Galavotti, et al. Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases. BMC Pulm Med. 2014;14:194. https://doi.org/10.1186/1471-2466-14-194.
Fernández-Pérez ER, Yilmaz M, Jenad H, Daniels CE, Ryu JH, Hubmayr RD, Gajic O. Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest. 2008;13:1113–9. https://doi.org/10.1378/chest.07-1481.
Gacouin A, Jouneau S, Letheulle J, Kerjouan M, Bouju P, Fillatre P, et al. Trends in prevalence and prognosis in subjects with acute chronic respiratory failure treated with noninvasive and/or invasive ventilation. Respir Care. 2015;60:210–8. https://doi.org/10.4187/respcare.03467.
Nava S, Rubini F. Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis. Thorax. 1999;54(5):390–5. https://doi.org/10.1136/thx.54.5.390.
Dreyfuss D, Ricard J-D, Saumon G. On the physiologic and clinical relevance of lung-borne cytokines during ventilator-induced lung injury. Am J Respir Crit Care Med. 2003;167:1467–147. https://doi.org/10.1164/rccm.200206-611CP.
Marchioni A, Tonelli R, Ball L, Fantini R, Castaniere I, Cerri S, et al. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome? Crit Care. 2018;22:80. https://doi.org/10.1186/s13054-018-2002-4.
Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Triantafillidou C, Tsangaris I, et al. Clinical review: idiopathic pulmonary fibrosis acute exacerbations—unravelling Ariadne’s thread. Crit Care. 2010;14:246. https://doi.org/10.1186/cc9241.
Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med. 2006;354:1775–86. https://doi.org/10.1056/NEJMoa052052.
Marchioni A, Tonelli R, Rossi G, Spagnolo P, Luppi F, Cerri S, et al. Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball”. Ann Intensive Care. 2020;10:13–22. https://doi.org/10.1186/s13613-020-0632-6.
Gungor G, Tatar D, Salturk C, Cimen P, Saltürk C, Çimen P, et al. Why do patients with interstitial lung diseases fail in the ICU? A 2-center cohort study. Respir Care. 2013;58:525–31. https://doi.org/10.4187/respcare.01734.
Gaudry S, Vincent F, Rabbat A, Nunes H, Crestani B, Naccache J, et al. Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. J Thorac Cardiovasc Surg. 2014;147:47–53. https://doi.org/10.1016/j.jtcvs.2013.06.039.
Rush B, Wiskar K, Berger L, Griesdale D. The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: a nationwide retrospective cohort analysis. Respir Med. 2016;111:72–6. https://doi.org/10.1016/j.rmed.2015.12.005.
Silva Santos P, Cruz C, Esquinas AM. Mechanical ventilation in idiopathic pulmonary fibrosis: unresolved dilemma. Respir Med. 2016;117:283. https://doi.org/10.1016/j.rmed.2016.04.003.
Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50:1602426. https://doi.org/10.1183/13993003.02426-2016.
Mooney JJ, Raimundo K, Chang E, Broder MS. Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden. BMC Pulm Med. 2017;17:84. https://doi.org/10.1186/s12890-017-0426-2.
Yokoyama T, Kondoh Y, Taniguchi H, Kataoka K, Kato K, Nishiyama O, et al. Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. Intern Med. 2010;49:1509–14. https://doi.org/10.2169/internalmedicine.49.3222.
Vianello A, Arcaro G, Battistella L, Pipitone E, Vio S, Concas A, et al. Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis. J Crit Care. 2014;29:562–7. https://doi.org/10.1016/j.jcrc.2014.03.019.
Tomii K, Tachikawa R, Chin K, Murase K, Handa T, Mishima M, et al. Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia. Intern Med Tokyo Jpn. 2010;49:1341–7. https://doi.org/10.2169/internalmedicine.49.3491.
Faverio P, De Giacomi F, Sardella L, Fiorentino G, Carone M, Salerno F, et al. Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights. BMC Pulm Med. 2018;18:70. https://doi.org/10.1186/s12890-018-0643-3.
Grasselli G, Vergnano B, Pozzi MR, Sala V, D’Andrea G, Scaravilli V, et al. Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS? Ann Intensive Care. 2017;7:98. https://doi.org/10.1186/s13613-017-0320-3.
L’Her E, Deye N, Lellouche F, Taille S, Demoule A, Fraticelli A, et al. Physiologic effects of noninvasive ventilation during acute lung injury. Am J Respir Crit Care Med. 2005;172:1112–8. https://doi.org/10.1164/rccm.200402-226OC.
Navalesi P, Costa R, Ceriana P, Carlucci A, Prinianakis G, Antonelli M, et al. Non-invasive ventilation in chronic obstructive pulmonary disease patients: helmet versus facial mask. Intensive Care Med. 2007;33(1):74–81. https://doi.org/10.1007/s00134-006-0391-3.
Antonelli M, Conti G, Pelosi P, Gregoretti C, Pennisi MA, Costa R, et al. New treatment of acute hypoxemic respiratory failure: non invasive pressure support ventilation delivered by helmet—a pilot controlled trial. Crit Care Med. 2002;30:602–8. https://doi.org/10.1097/00003246-200203000-00019.
Antonelli M, Pennisi MA, Pelosi P, Gregoretti C, Squadrone V, Rocco M, et al. Noninvasive positive pressure ventilation using a helmet in patients with acute exacerbation of chronic obstructive pulmonary disease: a feasibility study. Anesthesiology. 2004;100:16–24. https://doi.org/10.1097/00000542-200401000-00007.
Kallet RH, Diaz JV. The physiologic effects of noninvasive ventilation. Respir Care. 2009;54:102–15.
Racca F, Appendini L, Gregoretti C, Stra E, Patessio A, Donner CF, et al. Effectiveness of mask and helmet interfaces to deliver noninvasive ventilation in a human model of resistive breathing. J Appl Physiol. 2005;99:1262–71. https://doi.org/10.1152/japplphysiol.01363.2004.
Olivieri C, Longhini F, Cena T, Cammarota G, Vaschetto R, Messina A, et al. New versus conventional helmet for delivering noninvasive ventilation a physiologic, crossover randomized study in critically ill patients. Anesthesiology. 2016;124:101–8. https://doi.org/10.1097/ALN.0000000000000910.
Esquinas Rodriguez AM, Papadakos PJ, Carron M, Cosentini R, Chiumello D. Clinical review: helmet and non-invasive mechanical ventilation in critically ill patients. Crit Care. 2013;17:223. https://doi.org/10.1097/ALN.0000000000000910.
Chiumello D, Pelosi P, Carlesso E, Severgnini P, Aspesi M, Gamberoni C, et al. Noninvasive positive pressure ventilation delivered by helmet vs. standard face mask. Intensive Care Med. 2003;29:1671–9. https://doi.org/10.1007/s00134-003-1825-9.
Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y. Spontaneous breathing during lung-protective ventilation in an experimental acute lung injury model: high transpulmonary pressure associated with strong spontaneous breathing effort may worsen lung injury. Crit Care Med. 2012;40:1578–85. https://doi.org/10.1097/CCM.0b013e3182451c40.
Grieco DL, Menga LS, Eleuteri D, Antonelli M. Patient self-inflicted lung injury: implications for acute hypoxemic respiratory failure and ARDS patients on non-invasive support. Minerva Anestesiol. 2019;85:1014–23. https://doi.org/10.23736/S0375-9393.19.13418-9.
Chiumello D, Brioni M. Severe hypoxemia: which strategy to choose. Crit Care. 2016;20:132. https://doi.org/10.1186/s13054-016-1304-7.
Gattinoni L, Tonetti T, Cressoni M, Cadringher P, Herrmann P, Moerer O, et al. Ventilator-related causes of lung injury: the mechanical power. Intensive Care Med. 2016;42:1567–75. https://doi.org/10.1007/s00134-016-4505-2.
Marini JJ, Jaber S. Dynamic predictors of VILI risk: beyond the driving pressure. Intensive Care Med. 2016;42:1597–600. https://doi.org/10.1007/s00134-016-4534-x.
Xie Y, Wang Y, Liu K, Li X. Correlation analysis between mechanical power, transforming growth factor-β1, and connective tissue growth factor levels in acute respiratory distress syndrome patients and their clinical significance in pulmonary structural remodeling. Medicine (Baltimore). 2019;98(29):e16531. https://doi.org/10.1097/MD.0000000000016531.
Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–63. https://doi.org/10.1001/jama.270.24.2957.
Duan J, Han X, Bai L, Zhou L, Huang S. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2017;43:192–9. https://doi.org/10.1007/s00134-016-4601-3.
Esquinas AM. Fibrosing interstitial pneumonia: is mechanical ventilation always the final alternative for the intensivist? J Thorac Cardiovasc Surg. 2014;147:1113. https://doi.org/10.1016/j.jtcvs.2013.09.077.
Acknowledgements
Fabrizio Bigotti, PhD, and Francesca Niutta for revising the final draft of this paper.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Ventilatory mode, basic presssure, volume and flow waveforms_1 (MOV 30802 kb)
Ventilatory mode, basic presssure, volume and flow waveforms_2 (MOV 11819 kb)
Ventilatory mode, basic presssure, volume and flow waveforms_3 (MOV 18342 kb)
Ventilatory mode, basic presssure, volume and flow waveforms_4 (MOV 15689 kb)
Ventilatory mode, basic presssure, volume and flow waveforms_5 (MOV 14039 kb)
Ventilatory mode, basic presssure, volume and flow waveforms_6 (MOV 19727 kb)
Ventilatory mode, basic presssure, volume and flow waveforms: BIPAP Mode_1 (MOV 20894 kb)
Ventilatory mode, basic presssure, volume and flow waveforms: BIPAP Mode_2 (MOV 58798 kb)
Ventilatory mode, basic presssure, volume and flow waveforms: CPAP Mode_1 (MOV 33981 kb)
Ventilatory mode, basic presssure, volume and flow waveforms: CPAP Mode_2 (MOV 78519 kb)
Ventilatory mode, basic presssure, volume and flow waveforms: CPAP Mode_3 (MOV 21043 kb)
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Piervincenzi, E., Zampini, G., Perrotta, D. (2022). Noninvasive Ventilation: Continuous Positive Air Pressure Ventilation (CPAP) and Pressure Support Ventilation (PSV). In: Esquinas, A.M. (eds) Teaching Pearls in Noninvasive Mechanical Ventilation. Springer, Cham. https://doi.org/10.1007/978-3-030-71298-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-71298-3_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71297-6
Online ISBN: 978-3-030-71298-3
eBook Packages: MedicineMedicine (R0)